IDNA · iShares

iShares Genomics Immunology and Healthcare ETF

See how 59 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 21 August 2026Price temporarily unavailableCoverage limitations apply

Core valuation

Trailing P/E-55.35×79.74% coverage
Latest-quarter run-rate P/E-63.70×80.69% coverage
Trailing P/S3.74×76.81% coverage
Latest-quarter run-rate P/S3.81×79.07% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

HoldingWeightTrailing P/ETrailing P/S
MRNAMODERNA INC8.95%-18.03×25.88×
TWSTTWIST BIOSCIENCE6.16%-111.55×22.14×
RVMDREVOLUTION MEDICINES4.11%-25.39×Unavailable
GMAB.COGENMAB3.99%25.43×5.35×
BAYN.DEBAYER AG3.93%-22.20×1.06×
BNTXBIONTECH SE ADR3.87%UnavailableUnavailable
REGNREGENERON PHARMACEUTICALS3.84%20.31×6.02×
MRKMERCK & CO INC3.70%42.17×5.73×
INCYINCYTE CORP3.65%17.83×4.76×
VRTXVERTEX PHARMACEUTICALS3.59%32.06×11.38×

Top 10 of 59 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

  1. IBB · iShares Biotechnology ETF22.40% holdings overlap · US market
  2. GNOM · Global X Genomics & Biotechnology ETF20.27% holdings overlap · Nasdaq
  3. XBI · State Street SPDR S&P Biotech ETF19.15% holdings overlap · NYSE Arca
  4. BMED · iShares Health Innovation Active ETF18.12% holdings overlap · NYSE Arca
  5. IXJ · iShares Global Healthcare ETF14.79% holdings overlap · NYSE Arca

Sources and limitations

Holdings are sourced from iShares and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 21 August 2026. Informational research, not investment advice.

Wide tables can scroll horizontally.

ratio/fox calculates each ETF’s real P/E and P/S as if it was one single company.

ETFs

Loading ETF list
Page loading
ETFs with look-through P/E and P/S valuation and source details
ticker ETF P/E · trailing P/E · quarter P/S · trailing P/S · quarter issuer market listed on current price currency price in original currency price date price provider listing type relationship primary benchmark holdings forward P/E fwd P/E min fwd P/E max forward P/S fwd P/S min fwd P/S max earnings yield fwd earnings yield sales yield fwd sales yield trailing P/E value gap fwd P/E value coverage fwd P/E value gap trailing P/S value coverage trailing P/S value gap fwd P/S value coverage fwd P/S value gap coverage notes
Loading ETF list...